Delivery Order SPE2DB24D2010-SPE2DB25FZZT4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $55,373.90 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml in pen format. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. This delivery order falls...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SKYRIZI 150 MG/ML PenML, a pharmaceutical product, with a ceiling value of $26,166.64. This competitively awarded, firm fixed-price delivery order is set to conclude on August 19, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $26,546.03 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml pen, a pharmaceutical product. This firm fixed-price contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive delivery order issued without set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,788.01 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml pen/ml on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a $89,511.22 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen/mL pharmaceutical products on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed price contract is non-set-aside and utilizes AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML in pen/milliliter format, with a contract ceiling value of $20,981.41. This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $11,972.91 delivery order on August 19, 2025, for SKYRIZI 150 MG/ML pen/mL, a prescription biologic medication. This firm fixed price, competitively awarded contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $42,191.28 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen medication on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed price contract represents a non-competitive set-aside delivery against AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $18,136.65 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of August 22, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $53,255.41 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen medication, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub for federal...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FZZT4Delivery Order
The Defense Logistics Agency awarded a $63,561.98 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen/mL, a pharmaceutical product for federal medical supply needs. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of June 13, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains through competitive awards with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $63.6k | 6/12/25 |